Refine Search

New Search

Advanced search

Results: 416

(searched for: RISK-ASSESSMENT-OF-SUICIDE-IN-CLINICAL-PRACTICE)
Page of 42
Articles per Page
by
Show export options
  Select all
Sciprofile linkJennifer M. Boggs, Arne Beck, Debra P. Ritzwoller, Catherine Battaglia, Heather D. Anderson, Richard C. Lindrooth
Journal of General Internal Medicine pp 1-6; doi:10.1007/s11606-020-05641-4

The publisher has not yet granted permission to display this abstract.
Sciprofile linkMarcus D. Durham, Carl Armon, Jonathan D. Mahnken, Richard M. Novak, Frank Palella, Ellen Tedaldi, Sciprofile linkKate Buchacz, HOPS Investigators
Published: 3 February 2020
Preventive Medicine; doi:10.1016/j.ypmed.2020.106011

The publisher has not yet granted permission to display this abstract.
Sciprofile linkD. Driot, J. Nguyen-Soenen, M. Costes, M. Pomier, J. Birebent, S. Oustric, J. Dupouy
Published: 1 February 2020
L'Encéphale, Volume 46, pp 41-54; doi:10.1016/j.encep.2019.07.014

The publisher has not yet granted permission to display this abstract.
Sciprofile linkRuth Melia, Kady Francis, Emma Hickey, Sciprofile linkJohn Bogue, Sciprofile linkJim Duggan, Mary O'sullivan, Karen Young
Published: 15 January 2020
JMIR mHealth and uHealth, Volume 8; doi:10.2196/12516

Abstract: Digital interventions are proposed as one way by which effective treatments for self-harm and
suicidal
ideation may be improved and their scalability enhanced. Mobile devices offer a potentially powerful medium to deliver evidence-based interventions with greater specificity to the individual when the intervention is needed. The recent proliferation
of
publicly available mobile apps designed for
suicide
prevention underlines the need for robust evidence to promote safe
practice
. This review aimed to examine the effectiveness
of
currently available mobile health (mHealth) technology tools
in
reducing
suicide
-specific outcomes. The following databases were searched: Cochrane Central Register
of
Controlled Trials (The Cochrane Library), MEDLINE, EMBASE, PsycINFO, and relevant sources
of
gray literature. All published and unpublished randomized controlled trials (RCTs), pseudo-RCTs, and pre-post observational studies that evaluated the effectiveness
of
mHealth technology
in
suicide
prevention delivered via mobile computing and communication technology were included. Studies were included if they measured at least one
suicide
outcome variable (ie,
suicidal
ideation,
suicidal
intent, nonsuicidal self-injurious behavior, and
suicidal
behavior). A total
of
2 review authors independently extracted data and
assessed
study suitability,
in
accordance with the Cochrane Collaboration
Risk
of
Bias Tool, on July 31, 2018. Owing to the heterogeneity
of
outcomes found across studies, results were not amenable for pooled synthesis, and a meta-analysis was not performed. A narrative synthesis
of
the available research is presented here. A total
of
7 studies met criteria for inclusion . Four published articles that reported on the effectiveness
of
the following mobile phone apps were included: iBobbly, Virtual Hope Box, BlueIce, and Therapeutic Evaluative Conditioning. Results demonstrated some positive impacts for individuals at elevated
risk
of
suicide
or self-harm, including reductions
in
depression, psychological distress, and self-harm and increases
in
coping self-efficacy. None
of
the apps evaluated demonstrated the ability to significantly decrease
suicidal
ideation compared with a control condition.
In
addition, 3 unpublished and recently completed trials also met criteria for inclusion
in
the review. Further research is needed to evaluate the efficacy
of
stand-alone mHealth technology-based interventions
in
suicide
prevention. The small number
of
studies reported
in
this review tentatively indicate that such tools may have a positive impact on
suicide
-specific outcomes. Future mHealth intervention evaluations would benefit from addressing the following 3 main methodological limitations : (1) heterogeneity
of
outcomes: a lack
of
standardized measurement
of
suicide
outcomes across studies; (2) ecological validity: the tendency to exclude potential participants because
of
the elevated
suicide
risk
may reduce generalizability within
clinical
settings; and (3) app regulation and definition: the lack
of
a standardized classification system for mHealth intervention type points to the need for better definition
of
the scope
of
such technologies to promote safe
practice
. PROSPERO CRD42017072899; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=72899. RR2-10.2196/resprot.8635.
Sciprofile linkMary F. Cwik, Victoria M. O’Keefe, Emily E. Haroz
International Review of Psychiatry pp 1-11; doi:10.1080/09540261.2019.1693351

The publisher has not yet granted permission to display this abstract.
International Journal of Environmental Research and Public Health, Volume 17; doi:10.3390/ijerph17010284

Abstract: Psychological pain is a core
clinical
factor for understanding
suicide
, independently from depression. The aim
of
this study is to
assess
the role
of
psychological pain on
suicide
risk
and to evaluate the relationship between psychache and different psychiatric disorders. We conducted the present cross-sectional study on 291 inpatients with a diagnosis
of
major depressive disorder, bipolar disorder, and schizophrenia. We administered Shneidman's Psychological Pain
Assessment
Scale (PPAS) for the
assessment
of
mental pain and the Mini International Neuropsychiatric Interview (MINI) for the
assessment
of
suicide
risk
. There was a significant association between current psychache and worst-ever psychache and
suicide
risk
in
inpatients affected by a depressive disorder, bipolar disorder and schizophrenia. Furthermore, we found a significant difference
in
current psychache between inpatients with major depressive disorder and inpatients with schizophrenia and
in
worst-ever psychache between inpatients with bipolar disorder and inpatients with schizophrenia, with lower scores
in
inpatients with schizophrenia. The
assessment
of
psychache appears to be useful for predicting
suicidal
risk
and should be used routinely for identifying and treating
suicide
risk
in
clinical
practice
.
International Journal of Mental Health Nursing; doi:10.1111/inm.12685

The publisher has not yet granted permission to display this abstract.
Sithandazile Masuku
Published: 12 December 2019
British Journal of Nursing, Volume 28, pp 1468-1476; doi:10.12968/bjon.2019.28.22.1468

The publisher has not yet granted permission to display this abstract.
New version
Patrizia Natale, Suetonia C Palmer, Marinella Ruospo, Valeria M Saglimbene, Sciprofile linkKannaiyan S Rabindranath, Giovanni Fm Strippoli
Published: 2 December 2019
by Wiley
Cochrane Database of Systematic Reviews, Volume 12; doi:10.1002/14651858.CD004542.pub3

The publisher has not yet granted permission to display this abstract.
Nicola S. Gray, Jacqui Tiller, Sciprofile linkRobert J. Snowden
Published: 11 November 2019
The Journal of Forensic Practice, Volume 21, pp 228-239; doi:10.1108/jfp-06-2019-0025

The publisher has not yet granted permission to display this abstract.
Page of 42
Articles per Page
by
Show export options
  Select all